Cornerstone Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$507K Sell
5,097
-19
-0.4% -$2.48K 0.03% 448
2025
Q4
$622K Sell
5,116
-1,817
-26% -$228K 0.03% 374
2025
Q3
$778K Sell
6,933
-279
-4% -$32.7K 0.04% 326
2025
Q2
$966K Buy
7,212
+965
+15% +$106K 0.06% 266
2025
Q1
$420K Buy
6,247
+2,540
+69% +$175K 0.03% 405
2024
Q4
$231K Buy
+3,707
New +$345K 0.02% 525

Other funds holding TMDX

Cornerstone Wealth Management's TMDX Position: Q1 2026 in Review

Cornerstone Wealth Management reduced its Transmedics (TMDX) stake by 0.37% in Q1 2026, selling an estimated $2.48K and leaving 5,097 shares worth $507K. The position accounts for 0.03% of the portfolio, ranked #448.

Cornerstone Wealth Management first reported a position in TMDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $966K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Cornerstone Wealth Management held 5,097 shares of Transmedics worth $507K as of Q1 2026.
  • Cornerstone Wealth Management sold 19 Transmedics shares in Q1 2026, an estimated $2.48K.
  • Transmedics made up 0.03% of Cornerstone Wealth Management's portfolio in Q1 2026, its #448 holding.
  • Cornerstone Wealth Management first reported a position in Transmedics in Q4 2024 and has held it in 6 quarters since.
  • Cornerstone Wealth Management's Transmedics position peaked at $966K in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Cornerstone Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.